B. Greg Brown
About
B. Greg Brown is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, B. Greg Brown has authored 100 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 48 papers in Cardiology and Cardiovascular Medicine and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B. Greg Brown's work include Lipoproteins and Cardiovascular Health (50 papers), Cardiac Imaging and Diagnostics (35 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers). B. Greg Brown is often cited by papers focused on Lipoproteins and Cardiovascular Health (50 papers), Cardiac Imaging and Diagnostics (35 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers). B. Greg Brown collaborates with scholars based in United States, Canada and Italy. B. Greg Brown's co-authors include Edward L. Bolson, Harold T. Dodge, Xue-Qiao Zhao, J J Albers, James T. Dodge, D Sacco, Alberto Zambon, Xiaohui Zhao, John E. Hokanson and Steven E. Nissen and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.
In The Last Decade
B. Greg Brown
100 papers receiving 8.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| B. Greg Brown United States | 44 | 5.2k | 3.7k | 2.8k | 2.2k | 1.2k | 100 | 8.8k | ||
| Tim Crowe United States | 20 | 5.6k 1.1× | 2.1k 0.6× | 1.8k 0.7× | 1.9k 0.9× | 1.1k 0.9× | 38 | 7.3k | ||
| Christian Spaulding France | 30 | 7.5k 1.4× | 5.3k 1.4× | 1.8k 0.6× | 2.0k 0.9× | 1.3k 1.0× | 107 | 11.7k | ||
| John R. Crouse United States | 49 | 3.1k 0.6× | 3.9k 1.1× | 1.3k 0.5× | 1.6k 0.7× | 2.4k 1.9× | 110 | 8.4k | ||
| Prediman K. Shah United States | 25 | 3.5k 0.7× | 2.8k 0.8× | 1.7k 0.6× | 1.1k 0.5× | 890 0.7× | 56 | 6.0k | ||
| Robert M. Califf United States | 41 | 6.9k 1.3× | 5.7k 1.5× | 2.0k 0.7× | 1.6k 0.7× | 656 0.5× | 106 | 10.4k | ||
| Xue-Qiao Zhao United States | 33 | 3.5k 0.7× | 2.1k 0.6× | 1.1k 0.4× | 2.2k 1.0× | 1.1k 0.9× | 54 | 6.0k | ||
| Albert V.G. Bruschke Netherlands | 41 | 3.2k 0.6× | 3.1k 0.8× | 2.0k 0.7× | 1.1k 0.5× | 778 0.6× | 131 | 6.6k | ||
| Felicita Andreotti Italy | 45 | 5.8k 1.1× | 10.1k 2.7× | 2.6k 0.9× | 1.9k 0.9× | 935 0.8× | 179 | 15.2k | ||
| José López‐Sendón Spain | 56 | 4.1k 0.8× | 10.0k 2.7× | 1.7k 0.6× | 1.9k 0.9× | 1.3k 1.1× | 263 | 13.6k | ||
| J. Wayne Warnica Canada | 19 | 4.9k 0.9× | 3.2k 0.9× | 840 0.3× | 1.8k 0.8× | 542 0.4× | 31 | 7.6k |
Countries citing papers authored by B. Greg Brown
Since
Specialization
Citations
This map shows the geographic impact of B. Greg Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Greg Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Greg Brown more than expected).
Fields of papers citing papers by B. Greg Brown
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by B. Greg Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Greg Brown. The network helps show where B. Greg Brown may publish in the future.
Co-authorship network of co-authors of B. Greg Brown
This figure shows the co-authorship network connecting the top 25 collaborators of B. Greg Brown. A scholar is included among the top collaborators of B. Greg Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Greg Brown. B. Greg Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zhao, Xue-Qiao, Binh An P. Phan, Joseph Davis, et al.. (2016). Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study—Observational Study. Journal of clinical lipidology. 10(5). 1091–1097.
2.
Zhao, Xue, Joseph Davis, Daniel Isquith, et al.. (2014). MORTALITY REDUCTION IN PATIENTS TREATED WITH LONG-TERM INTENSIVE LIPID THERAPY: 20-YEAR FOLLOW-UP OF THE FAMILIAR ATHEROSCLEROSIS TREATMENT STUDY- OBSERVATIONAL STUDY. Journal of the American College of Cardiology. 63(12). A1287–A1287.
3.
Phan, Binh An P., A. Moore, Joseph Davis, et al.. (2014). Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: A case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS). Journal of clinical lipidology. 8(5). 489–493.
4.
Zambon, Alberto, Xue-Qiao Zhao, B. Greg Brown, & John D. Brunzell. (2014). Effects of Niacin Combination Therapy With Statin or Bile Acid Resin on Lipoproteins and Cardiovascular Disease. The American Journal of Cardiology. 113(9). 1494–1498.
5.
Guyton, John R., B. Greg Brown, Sergio Fazio, et al.. (2008). Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia. Journal of the American College of Cardiology. 51(16). 1564–1572.
6.
Brown, B. Greg & Xue-Qiao Zhao. (2008). Nicotinic Acid, Alone and in Combinations, for Reduction of Cardiovascular Risk. The American Journal of Cardiology. 101(8). S58–S62.
7.
Vittone, F., et al.. (2007). Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study. Journal of clinical lipidology. 1(3). 203–210.
8.
Brown, B. Greg & Xue-Qiao Zhao. (2007). Is Intravascular Ultrasound the Gold Standard Surrogate for Clinically Relevant Atherosclerosis Progression?. Journal of the American College of Cardiology. 49(9). 933–938.
9.
Cheung, Marian C., B. Greg Brown, Emily K. Larsen, et al.. (2005). Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(1). 131–137.
10.
Taylor, Allen J., Leslee J. Shaw, Zahi A. Fayad, et al.. (2005). Tracking atherosclerosis regression: a clinical tool in preventive cardiology. Atherosclerosis. 180(1). 1–10.
11.
Zhao, Xue-Qiao, Alice Dowdy, Jiří Fröhlich, et al.. (2004). Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). The American Journal of Cardiology. 93(3). 307–312.
12.
Matthan, Nirupa R., et al.. (2003). Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. Journal of Lipid Research. 44(4). 800–806.
13.
Cheung, Marian C., Gertrud Wolfbauer, Hal Kennedy, B. Greg Brown, & John J. Albers. (2001). Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537(2). 117–124.
14.
Brown, B. Greg & Xue-Qiao Zhao. (1998). Importance of endothelial function in mediating the benefits of lipid-lowering therapy. The American Journal of Cardiology. 82(10). 49–52.
15.
Brown, B. Greg, Lynn A. Hillger, Alice Dowdy, et al.. (1997). Moderate Dose, Three-Drug Therapy With Niacin, Lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients With Hyperlipidemia and Coronary Artery Disease. The American Journal of Cardiology. 80(2). 111–115.
16.
Brown, B. Greg, et al.. (1997). Secondary prevention of heart disease amongst patients with lipid abnormalities: practice and trends in the United States. Journal of Internal Medicine. 241(4). 283–294.
17.
Brown, B. Greg, et al.. (1991). Increased potential for regression of post-PTCA restenosis using intensive lipld-altering therapy: Comparison with matched non-PTCA lesions. Journal of the American College of Cardiology. 17(2). A230–A230.
18.
Brown, B. Greg, et al.. (1990). Apolipoprotein B, a hidden risk factor among patients requiring invasive therapy for coronary artery disease. Journal of the American College of Cardiology. 15(2). A115–A115.
19.
Cukingnan, Ramon A., B. Greg Brown, John H. Wittig, & Joseph S. Carey. (1982). Hemodynamic effect of myocardial revascularization in the impaired ventricle. Journal of Thoracic and Cardiovascular Surgery. 83(5). 711–717.
20.
Cukingnan, Ramon A., Joseph S. Carey, John H. Wittig, & B. Greg Brown. (1980). Influence of complete coronary revascularization on relief of angina. Journal of Thoracic and Cardiovascular Surgery. 79(2). 188–193.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tim Crowe Breakdown of academic impact, for papers by Christian Spaulding Breakdown of academic impact, for papers by John R. Crouse Breakdown of academic impact, for papers by Prediman K. Shah Breakdown of academic impact, for papers by Robert M. Califf Breakdown of academic impact, for papers by Xue-Qiao Zhao Breakdown of academic impact, for papers by Albert V.G. Bruschke Breakdown of academic impact, for papers by Felicita Andreotti Breakdown of academic impact, for papers by José López‐Sendón Breakdown of academic impact, for papers by J. Wayne Warnica